IM Cannabis (IMCC) Return on Equity (2026)
IM Cannabis (IMCC) recorded quarterly Return on Equity of 0.03% in Q1 2026.
IM Cannabis (IMCC) Return on Equity (2026) Analysis & Trends
IM Cannabis' Return on Equity history runs 1 years deep, the most recent figure standing at 0.03% for Q1 2026.
- In Q1 2026, Return on Equity changed N/A year-over-year to 0.03%; the TTM figure through Mar 2026 stood at 0.03% (changed N/A YoY), while the FY2025 annual figure was 0.15%, changed N/A from the prior year.
- Return on Equity was 0.03% for Q1 2026 at IM Cannabis.
- In the past five years, Return on Equity ranged from a high of 0.03% in Q1 2026 to a low of 0.03% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.00% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.01% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 0.00% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.00% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 0.00% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.00% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.00% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.00% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 0.00% |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | 0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.03% |